Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve Unaudited ....
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has informed the stock exchanges that its Board of Directors will meet on Monday, 4 August 2025. The main agenda is to consider and approve the Unaudited Financial Results for the quarter and half-year ended 30 June 2025 (Q1 FY26). The company has also confirmed that the trading window for designated persons is closed from 1 July 2025 to 6 August 2025, in line with its insider trading code. This is a standard regulatory filing under SEBI LODR Regulation 29 ahead of the quarterly results announcement.
No direct impact on shareholders from this intimation itself. Investors should watch for the actual Q1 FY26 results on or after 4 August 2025 for revenue, profit, and margin trends in the consumer healthcare business.